Actively Recruiting
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
Led by University of Rhode Island · Updated on 2025-12-09
80
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
Sponsors
U
University of Rhode Island
Lead Sponsor
R
Rhode Island Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a two-part study to develop and test a brief, virtual therapy program for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people who have experienced trauma and use alcohol. Phase 1: You'll be invited to share your perspective to help make the program relevant, inclusive, and affirming. Phase 2: You may have the opportunity to try the adapted program by receiving free virtual therapy with LGBTQ+-affirming therapists.
CONDITIONS
Official Title
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
Who Can Participate
Eligibility Criteria
You may qualify if you...
Aim 1: Sexual Minority Women and Transgender and Gender Diverse Individuals -Not meeting inclusion criteria
Aim 1: Providers
-Not meeting inclusion criteria
Aim 2: Sexual Minority Women and Transgender and Gender Diverse Individuals
- Not meeting inclusion criteria OR any of the following:
- Reporting current mental health treatment ≥1 day/month
- Receiving Cognitive Behavioral Therapy (CBT) in the past 3 months (note: participants are not ineligible if they seek concomitant care after enrollment)
- Reporting current alcohol or drug use disorder treatment, except mutual self-help (e.g., Alcoholics Anonymous) or current PTSD/trauma-focused treatment
- Need for alcohol detoxification, defined as score ≥15 on the adapted self-report Clinical Institute Withdrawal Assessment for Alcohol - Revised (CIWA-Ar)
- Active psychosis, defined as score ≥1 on the psychosis subscale of the Behavior and Symptom Identification Scale - Revised (BASIS-R)
- Active mania, defined as score ≥6 on the Altman Self-Rating Mania Scale (ASRM)
- Active suicidality, defined as score ≥22 on the Suicidal Ideation Attributes Scale (SIDAS)
- Currently legally mandated to attend treatment
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Rhode Island
Providence, Rhode Island, United States, 02860
Actively Recruiting
Research Team
J
Jillian Scheer, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here